Continuing development of the Gestational and also Lactational Physiologically Dependent Pharmacokinetic (PBPK) Model pertaining to Perfluorooctane Sulfonate (PFOS) throughout Subjects and People and Its Ramifications in the Derivation of Health-Based Toxic body Valuations. | #saha #regorafenib #lorlatinib #fulvestrant #tofacitinib #iron sucrose #b02